: Efforts to maximize the benefits and minimize the risks associated with drugs continue to be impeded by suboptimal prescribing, inadequate monitoring of patients' outcomes, and inadequate prescriber education and support to overcome these limitations. As a result, the US healthcare system suffers from persistent problems of underuse, overuse and misuse of drugs, with unacceptably high rates of preventable errors, adverse effects and suboptimal patient health outcomes. To address these problems, we propose a CERT organized around the following theme: Tools for Optimizing Prescribing, Monitoring and Education (TOP-MED). The long term objective of our CERT is to improve the safety, efficacy and cost-effectiveness of drug therapy by increasing the appropriateness of prescribing and the quality of monitoring. The short term objective is to develop, redesign, refine, integrate, test, deploy and disseminate tools and training materials in five key areas: drug formularies, drug utilization review, lab-pharmacy linkages, N-of-1 trials and pharmacoeconomics. To achieve these objectives, the TOP-MED CERT will pursue the following specific aims: ? 1. Revitalize the drug formulary as an evidenced based tool for directing drug therapy decisions. ? 2. Re-engineer drug usage review (DUR) systems and processes so that data analysis is easier, more timely and more likely to yield valid generalizations. ? 3. Reduce prescribing errors and enhance recognition of adverse drug effects in high hazard contexts by linking lab and pharmacy information systems and generating clinical alerts when problems are detected. ? 4. Develop, deploy and evaluate an N-of-1 trial service, integrated into a formulary restriction program, in order to support the goal of individualized therapy without succumbing to the unsafe, unscientific experimentation that is often now the norm. ? 5. Implement and study the impact of pharmacoeconomic support to enhance formulary decision making, as well as evaluate the cost-effectiveness of other interventions. ? Cutting across these five aims will be initiatives to disseminate and deploy these tools in a more rigorous and far-reaching fashion; to provide support to make the tools easier to use; to enhance the buy-in, motivation and enthusiasm of prescribers to use the tools; to link the tools with each other in order to gain greater synergies, and to share the knowledge gained and lessons learned across multiple institutions. Headquartered at the University of Illinois at Chicago (UIC), and leveraging collaborations with the Cook County Bureau of Health Services, Northwestern Memorial Hospital, University of Washington, the VA Center for Medication Safety, Advocate Health Care, the Illinois Hospital Association and the Illinois Department of Public Health, the TOPMED CERT will be able to focus on the needs of multiple AHRQ priority populations. ? ? ?

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Demonstration--Cooperative Agreements (U18)
Project #
1U18HS016973-01
Application #
7333917
Study Section
Special Emphasis Panel (ZHS1-HSR-O (01))
Program Officer
Kelly, Carmen
Project Start
2007-09-01
Project End
2011-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
1
Fiscal Year
2007
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Administration
Type
Schools of Pharmacy
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Gibbons, Robert D; Brown, C Hendricks; Hur, Kwan et al. (2013) Suicide risk and efficacy of antidepressant drugs--reply. JAMA Psychiatry 70:123-5
Galanter, William L; Applebaum, Andrew; Boddipalli, Viveka et al. (2013) Migration of patients between five urban teaching hospitals in Chicago. J Med Syst 37:9930
Gibbons, Robert D; Brown, C Hendricks; Hur, Kwan et al. (2013) Inappropriate data and measures lead to questionable conclusions--reply. JAMA Psychiatry 70:122-3
Gibbons, Robert D; Brown, C Hendricks; Hur, Kwan et al. (2012) Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:580-7
Schiff, Gordon D; Galanter, William L; Duhig, Jay et al. (2012) A prescription for improving drug formulary decision making. PLoS Med 9:1-7
Alexander, G Caleb; Lambert, Bruce L (2012) Is treatment heterogeneity an Achilles' heel for comparative effectiveness research? Pharmacotherapy 32:583-5
Touchette, Daniel R; Yang, Yoojung; Tiryaki, Funda et al. (2012) Economic analysis of alvimopan for prevention and management of postoperative ileus. Pharmacotherapy 32:120-8
Steinman, Michael A; Handler, Steven M; Gurwitz, Jerry H et al. (2011) Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 59:1513-20
Tiryaki, Funda; Nutescu, Edith A; Hennenfent, Joel A et al. (2011) Anticoagulation therapy for hospitalized patients: patterns of use, compliance with national guidelines, and performance on quality measures. Am J Health Syst Pharm 68:1239-44
Yu, Shengsheng; Galanter, William L; DiDomenico, Robert J et al. (2011) Selection of drug-laboratory result pairs for an inpatient asynchronous alert program: results of a Delphi survey. Am J Health Syst Pharm 68:407-14

Showing the most recent 10 out of 20 publications